GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation

GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation

Aims: To determine whether the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) integrated risk tool predicts mortality, non-haemorrhagic stroke/systemic embolism, and major bleeding for up to 2 years after new-onset AF and to assess how this risk tool performs compared w...

Full description

Bibliographic Details
Main Authors: Bassand, J.-P (Author), Camm, A.J (Author), Dalgaard, F. (Author), Fitzmaurice, D.A (Author), Fox, K.A.A (Author), Goldhaber, S.Z (Author), Goto, S. (Author), Haas, S. (Author), Kakkar, A.K (Author), Kayani, G. (Author), Misselwitz, F. (Author), Oto, A. (Author), Piccini, J.P (Author), Pieper, K.S (Author), Turpie, A.G.G (Author), Verheugt, F.W.A (Author), Virdone, S. (Author)
Format: Article
Language:English
Published: Oxford University Press 2022
Subjects:
adult
aged
all cause mortality
anticoagulant agent
anticoagulant therapy
antithrombocytic agent
antivitamin K
Article
atrial fibrillation
Atrial fibrillation
bleeding
brain hemorrhage
cerebrovascular accident
CHA2DS2 VASc risk score
CHA2DS2-VASc
clinical feature
cohort analysis
comparative study
controlled study
Danish citizen
death
decision making
demography
disease risk assessment
female
follow up
GARFIELD AF risk score
GARFIELD-AF
HAS BLED risk score
human
least absolute shrinkage and selection operator
lifestyle
low risk population
major clinical study
male
mortality
prediction
proportional hazards model
Risk stratification
treatment outcome
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items